Roger Crystal, Chief Executive Officer, 10% Owner at OPIANT PHARMACEUTICALS, INC. (OPNT), bought 100 shares at $23.44 ($2K) on 2021-09-16, disclosed to the SEC on 2021-09-16.
Open-market purchase of $2k OPNT by Chief Executive Officer, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| OPNT | SELL | 2023-01-05 | $203K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $25K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $104K | — | Filing → |